Home Healthcare Pharmaceuticals Antiviral Drugs Market

Antiviral Drugs Market Size, Share & Trends Analysis Report By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, RNAi Antisense Therapeutics, Capsid Inhibitors, Others), By Application (HIV, Hepatitis, Herpes, Influenza, Respiratory Syncytial Virus, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 21, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
  7. North America Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
  8. Europe Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    7. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
  9. APAC Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    8. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
  10. Middle East and Africa Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
  11. LATAM Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
  12. Competitive Landscape
    1. Antiviral Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Hoffmann-La Roche Ltd. (Switzerland)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Gilead Sciences, Inc. (US)
    3. Merck Co., Inc. (US)
    4. Pfizer Inc. (US)
    5. AbbVie Inc. (US)
    6. Johnson & Johnson (US)
    7. Bristol Myers Squibb (US)
    8. Viatris Inc. (US)
    9. GSK plc (UK)
    10. Sanofi S.A. (France)
    11. Boehringer Ingelheim International GmbH (Germany)
    12. Teva Pharmaceutical Industries Ltd. (Israel)
    13. Reddy's Laboratories Ltd. (India)
    14. Cipla Limited (India)
    15. Sun Pharmaceutical Industries Ltd. (India)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.